ArticleJournal of functional biomaterials2026
Evaluation of Natural Polyphenols Encapsulated in Multiparticulate Drug Delivery Systems as Potential Therapeutics for Cutaneous Melanoma.
Article in Journal of functional biomaterials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Nutraceuticals are bioactive compounds that can contribute to maintaining general health and supporting the treatment of various conditions. Among them, flavonoids such as curcumin (C) and quercetin (Q) are of particular interest in oncology research, including melanoma, due to their anti-tumor effects. However, due to poor bioavailability, the development of efficient delivery vehicles is of utmost importance. In this context, we aimed to assess the effectiveness of a potential treatment on the progression of cutaneous melanoma by evaluating cell viability and proliferation in the presence of encapsulated C/Q in innovative microcapsules (MDDS) embedded in a collagen matrix, as well as the anti-inflammatory and antioxidant potential. We found that tumor cell viability and proliferation were significantly reduced in the presence of C/Q, with the best results being obtained for the composite with both bioactive compounds, these results were also supported by a significant increase in pro-apoptotic markers. A decrease in pro-inflammatory markers was observed, as well as a decrease in ROS secretion over time, indicating the anti-inflammatory and antioxidant potential of the materials supplemented with the tested flavonoids, these properties being important for TME modulation. Therefore, the MDDS-CQ embedded sponge could represent a potential adjuvant therapy for cutaneous melanoma in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.